{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:55:27Z","timestamp":1788368127013,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021267","name":"ANZ Breast Cancer Trials Group Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021267","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.breast.2025.104482","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T02:46:25Z","timestamp":1745376385000},"page":"104482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Current pattern of care in radiation therapy for DCIS in Australia and New Zealand - where are we heading?"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4940-4674","authenticated-orcid":false,"given":"Adam","family":"Ofri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Ki","family":"Melanie Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suki","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Spillane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2025.104482_bib1","series-title":"Breast ductal carcinoma in situ","author":"Tomlinson-Hansen","year":"2023"},{"issue":"3","key":"10.1016\/j.breast.2025.104482_bib2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0969141320945736","article-title":"Estimating the natural progression of non-invasive ductal carcinoma in situ breast cancer lesions using screening data","volume":"28","author":"Weedon-Fekj\u00e6r","year":"2021","journal-title":"J Med Screen"},{"key":"10.1016\/j.breast.2025.104482_bib3","series-title":"Welfare, BreastScreen Australia monitoring report 2023","author":"Health","year":"2023"},{"issue":"11","key":"10.1016\/j.breast.2025.104482_bib4","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/bjc.2013.177","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"108","author":"Marmot","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.breast.2025.104482_bib5","article-title":"Benefits and harms of breast cancer screening revisited: a large, retrospective cross-sectional study quantifying treatment intensity in women with screen-detected versus non-screen-detected cancer in Australia and New Zealand","volume":"2","author":"Dempsey","year":"2023","journal-title":"BMJ Oncol"},{"issue":"12","key":"10.1016\/j.breast.2025.104482_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv263","article-title":"Trends in treatment patterns and outcomes for ductal carcinoma in situ","volume":"107","author":"Worni","year":"2015","journal-title":"J Natl Cancer Inst: J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.breast.2025.104482_bib7","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/ans.16970","article-title":"The management of women with ductal carcinoma in situ of the breast in Australia and New Zealand between 2007 and 2016","volume":"91","author":"Omling","year":"2021","journal-title":"ANZ J Surg"},{"issue":"32","key":"10.1016\/j.breast.2025.104482_bib8","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma in Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial","volume":"31","author":"Donker","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2025.104482_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.breast.2025.104482_bib10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1200\/JCO.2007.12.7969","article-title":"Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast","volume":"26","author":"Holmberg","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2025.104482_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","article-title":"Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.breast.2025.104482_bib12","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJM199905133401902","article-title":"The influence of margin width on local control of ductal carcinoma in situ of the breast","volume":"340","author":"Silverstein","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.breast.2025.104482_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0960-9776(03)00153-X","article-title":"Ductal carcinoma in situ: USC\/Van Nuys Prognostic Index and the impact of margin status","volume":"12","author":"Silverstein","year":"2003","journal-title":"Breast"},{"issue":"41","key":"10.1016\/j.breast.2025.104482_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"2010","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"19","key":"10.1016\/j.breast.2025.104482_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194545","article-title":"De-escalating the management of in situ and invasive breast cancer","volume":"14","author":"Angarita","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.breast.2025.104482_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1069059","article-title":"Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma in situ","volume":"13","author":"Dabbs","year":"2023","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.breast.2025.104482_bib17","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/jso.20711","article-title":"Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast","volume":"95","author":"Buchholz","year":"2007","journal-title":"J Surg Oncol"},{"issue":"8","key":"10.1016\/j.breast.2025.104482_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jso.20708","volume":"95","author":"Silverstein","year":"2007","journal-title":"J Surg Oncol"},{"issue":"9","key":"10.1016\/j.breast.2025.104482_bib19","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1798::AID-CNCR15>3.0.CO;2-0","article-title":"Consensus conference on the classification of ductal carcinoma in situ. The Consensus conference committee","volume":"80","author":"Committe","year":"1997","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.breast.2025.104482_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"Rtog 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.breast.2025.104482_bib21","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1200\/JCO.21.01083","article-title":"Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG oncology\/RTOG 9804","volume":"39","author":"McCormick","year":"2021","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.breast.2025.104482_bib22","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1200\/JCO.2009.21.8560","article-title":"Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group","volume":"27","author":"Hughes","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2025.104482_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41523-024-00622-w","article-title":"Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 study","volume":"10","author":"Wright","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.breast.2025.104482_bib24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(22)01246-6","article-title":"Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07\/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study","volume":"400","author":"Chua","year":"2022","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.breast.2025.104482_bib25","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - the LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.breast.2025.104482_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"issue":"16","key":"10.1016\/j.breast.2025.104482_bib27","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2025.104482_bib28","author":"Iwata"},{"issue":"11","key":"10.1016\/j.breast.2025.104482_bib29","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jama.2024.26698","article-title":"Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ: the COMET randomized clinical trial","volume":"333","author":"Hwang","year":"2025","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.breast.2025.104482_bib30","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/jnci\/djg097","article-title":"Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy","volume":"95","author":"Kerlikowske","year":"2003","journal-title":"J Natl Cancer Inst: J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.breast.2025.104482_bib31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/0284186X.2023.2245552","article-title":"Outcome of different radiotherapy strategies after breast conserving surgery in patients with ductal carcinoma in situ (DCIS)","volume":"62","author":"W\u00e4rnberg","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.breast.2025.104482_bib32","series-title":"Breast Cancer (version 4.2025)","year":"2025"},{"key":"10.1016\/j.breast.2025.104482_bib33","author":"Samverkan"},{"issue":"4","key":"10.1016\/j.breast.2025.104482_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1100","article-title":"Association of radiotherapy with survival in women treated for ductal carcinoma in situ with lumpectomy or mastectomy","volume":"1","author":"Giannakeas","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.breast.2025.104482_bib35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ajpath.2018.08.020","article-title":"Ductal carcinoma in situ biomarkers in a precision medicine era: current and future molecular-based testing","volume":"189","author":"Shee","year":"2019","journal-title":"Am J Pathol"},{"issue":"15","key":"10.1016\/j.breast.2025.104482_bib36","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1158\/1078-0432.CCR-19-1152","article-title":"Validation of a ductal carcinoma in situ biomarker profile for risk of recurrence after breast-conserving surgery with and without radiotherapy","volume":"26","author":"Weinmann","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.breast.2025.104482_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12052036","article-title":"Molecular signatures in ductal carcinoma in situ (DCIS): a systematic review and meta-analysis","volume":"12","author":"Ouattara","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.breast.2025.104482_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clbc.2018.07.018","article-title":"Including the ductal carcinoma-in-situ (DCIS) score in the development of a multivariable prediction model for recurrence after excision of DCIS","volume":"19","author":"Paszat","year":"2019","journal-title":"Clin Breast Cancer"},{"issue":"10","key":"10.1016\/j.breast.2025.104482_bib39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"10.1016\/j.breast.2025.104482_bib40","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-18-0842","article-title":"A biological signature for breast ductal carcinoma in situ to predict radiotherapy benefit and assess recurrence risk","volume":"24","author":"Bremer","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.breast.2025.104482_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijrobp.2022.06.072","article-title":"A novel biosignature identifies patients with DCIS with high risk of local recurrence after breast conserving surgery and radiation therapy","volume":"115","author":"Vicini","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.breast.2025.104482_bib42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-015-3464-6","article-title":"A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone","volume":"152","author":"Rakovitch","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.breast.2025.104482_bib43","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1245\/s10434-021-09903-1","article-title":"The clinical utility of DCISionRT(\u00ae) on radiation therapy decision making in patients with ductal carcinoma in situ following breast-conserving surgery","volume":"28","author":"Shah","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"9_Supplement","key":"10.1016\/j.breast.2025.104482_bib44","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS23-PO4-22-05","article-title":"Abstract PO4-22-05: changes in treatment recommendation for patients with ductal carcinoma in situ using a 7-gene predictive biosignature: analysis of the PREDICT Australia study","volume":"84","author":"Zissiadis","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2025.104482_bib45","series-title":"Welfare, Radiotherapy in Australia 2018\u201319","author":"Health","year":"2020"},{"issue":"5","key":"10.1016\/j.breast.2025.104482_bib46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1470-2045(20)30085-1","article-title":"Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07\/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial","volume":"21","author":"King","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.breast.2025.104482_bib47","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/j.clbc.2020.10.007","article-title":"Cost-effectiveness analysis of biological signature DCISionRT use for DCIS treatment","volume":"21","author":"Kim","year":"2021","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1016\/j.breast.2025.104482_bib48","doi-asserted-by":"crossref","first-page":"pkaa004","DOI":"10.1093\/jncics\/pkaa004","article-title":"Cost effectiveness of DCISionRT for guiding treatment of ductal carcinoma in situ","volume":"4","author":"Raldow","year":"2020","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"10.1016\/j.breast.2025.104482_bib49","article-title":"Decision aids for people facing health treatment or screening decisions","author":"Stacey","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.breast.2025.104482_bib50","article-title":"Shared decision making in the care of patients with cancer","volume":"43","author":"Shickh","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"9","key":"10.1016\/j.breast.2025.104482_bib51","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.pec.2017.04.009","article-title":"Treatment decision-making in ductal carcinoma in situ: a mixed methods systematic review of women's experiences and information needs","volume":"100","author":"Rutherford","year":"2017","journal-title":"Patient Educ Counsel"}],"updated-by":[{"DOI":"10.1016\/j.breast.2025.104582","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000}},{"DOI":"10.1016\/j.breast.2025.104582","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625004990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625004990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T03:09:48Z","timestamp":1769656188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977625004990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":51,"alternative-id":["S0960977625004990"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104482","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current pattern of care in radiation therapy for DCIS in Australia and New Zealand - where are we heading?","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104482"}}